Showing 1171-1180 of 20877 results for "".
- Antibiotic Use During GI Infection Linked to Higher IBS Riskhttps://reachmd.com/news/antibiotic-use-during-gi-infection-linked-to-higher-ibs-risk/2486672/Key Takeaways Pooled estimates suggested higher IBS incidence among patients who received antibiotics than among those who did not, with very high heterogeneity across studies. In analyses limited to gastrointestinal infections, the pooled IRR was 1.71
- IEC Establishes Global Definitions for AD Disease Control and Remissionhttps://reachmd.com/news/iec-establishes-global-definitions-for-ad-disease-control-and-remission/2486652/A new consensus statement from the International Eczema Council (IEC) proposes standardized definitions for low disease activity (LDA), very low disease activity (vLDA), and remission in atopic dermatitis (AD), addressing what authors noted as a longstanding gap in
- Evaluating a Peer Navigator Intervention for Opioid-Related Overdosehttps://reachmd.com/news/peer-navigator-intervention-opioid-overdose/2486633/Key Takeaways: In a randomized four-site emergency department trial, investigators found no significant difference in opioid-related adverse events between a peer navigator intervention and site-directed care. The Relay model began in the emergency dep
- AI Dermatology Tools Improve Patient Diagnostic Accuracy in Survey Studyhttps://reachmd.com/news/ai-dermatology-tools-improve-patient-diagnostic-accuracy-in-survey-study/2486637/An AI-powered dermatology application was associated with improved consumer understanding of skin conditions, according to new research published in JAMA Dermatology. The study includ
- Remimazolam Matches Propofol In Postoperative ICU Sedation Trialhttps://reachmd.com/news/remimazolam-matches-propofol-in-postoperative-icu-sedation-trial/2486614/A paper reports results from a multicenter, randomized, single-blind, actively controlled phase 3 non-inferiority trial comparing remimazolam tosylate with propofol, with sedation success rates
- Analysis: No Lymphoma Signal With Topical Calcineurin Inhibitorshttps://reachmd.com/news/analysis-no-lymphoma-signal-with-topical-calcineurin-inhibitors/2486626/A recent pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database found no significant association between topical calcineurin inhibitors (TCIs) and lymphoma, despite longstanding boxed warnings in the United States.
- Interim IIT Data Explore Sculptra, Restylane for Menopause, Weight Loss–Related Aesthetic Changeshttps://reachmd.com/news/interim-iit-data-explore-sculptra-restylane-for-menopause-weight-lossrelated-aesthetic-changes/2486595/Interim findings from 2 ongoing investigator-initiated trials supported by Galderma suggest potential roles for Sculptra and the Restylane portfolio in treating aesthetic changes associated with menopause and medication-driven weight loss. In one interim analysis led by Sabrina Fabi, MD, 2
- Ucla Listing Details Phase 2 Ianalumab Study In DcSSchttps://reachmd.com/news/ucla-listing-details-phase-2-ianalumab-study-in-dcssc/2486578/Key Takeaways: The listing describes an actively recruiting phase 2 placebo-controlled study of subcutaneous ianalumab in diffuse cutaneous systemic sclerosis. Enrollment is limited by protocol-defined diagnosis, age, disease-duration, and baseline ski
- Central Pathology Review Finds Discordance In LNG IUD Trialhttps://reachmd.com/news/central-pathology-review-finds-discordance-in-lng-iud-trial/2486579/Key Takeaways: Interobserver agreement was reported at baseline and at both post-treatment timepoints. Discordance was reported more often in site-labeled hyperplasia than adenocarcinoma, and discordant cases were frequently upgraded on central review.
- Ketamine Trial Finds No Recovery Benefit, Higher ICU Transferhttps://reachmd.com/news/ketamine-trial-finds-no-recovery-benefit-higher-icu-transfer/2486580/Key Takeaways: Ketamine in major abdominal ERAS care was reported not to reduce hospital length of stay or opioid use versus placebo. In this trial, ketamine was associated with lower odds of meeting early discharge milestones and higher odds of ICU tr